MARKET

CGEN

CGEN

Compugen
NASDAQ
1.510
-0.010
-0.66%
Pre Market: 1.520 +0.01 +0.66% 06:13 12/19 EST
OPEN
1.550
PREV CLOSE
1.520
HIGH
1.590
LOW
1.510
VOLUME
5
TURNOVER
0
52 WEEK HIGH
2.660
52 WEEK LOW
1.130
MARKET CAP
141.24M
P/E (TTM)
-5.0468
1D
5D
1M
3M
1Y
5Y
1D
Compugen rises on royalty deal with AstraZeneca
Seeking Alpha · 1d ago
Compugen Secures $90 Million in a Strategic Royalty Monetization Deal with AstraZeneca
TipRanks · 1d ago
Compugen and AstraZeneca agree to monetize rilvegostomig future royalties
TipRanks · 1d ago
Compugen Agrees With AstraZeneca To Monetize Portion Of Compugen's Rilvegostomig Future Royalties
Benzinga · 1d ago
Weekly Report: what happened at CGEN last week (1208-1212)?
Weekly Report · 4d ago
Gilead and Arcus halt late-stage study for anti-TIGIT cancer drug
Seeking Alpha · 6d ago
Weekly Report: what happened at CGEN last week (1201-1205)?
Weekly Report · 12/08 10:38
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 12/05 21:05
More
About CGEN
Compugen Ltd. is a therapeutic discovery company. The Company focuses on infrastructure to discover drug targets and develop therapeutics. The Company is engaged in the research, development and commercialization of therapeutic and product candidates. The Company's pipeline primarily consists of early and preclinical stage immuno-oncology programs based on drug targets discovered by the Company, primarily immune checkpoint and myeloid protein target candidates. These programs are focused on the development of cancer immunotherapy drugs with potential to harness the immune system to provide treatment solutions in areas of unmet medical needs in various cancer types and patient populations, both as monotherapy and in combination with other drugs. Its pipeline also includes a preclinical stage fusion protein autoimmune product candidate. Its fields of focus are oncology and immunology, with emphasis on its discovery capabilities on immuno-oncology.

Webull offers Compugen Ltd (USA) stock information, including NASDAQ: CGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CGEN stock methods without spending real money on the virtual paper trading platform.